Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision changed from v3.3.1 to v3.3.2, which appears to be an administrative metadata update and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T06:00:05.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision history updated from v3.2.0 to v3.3.1; no substantive changes to the study details observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-21T02:13:38.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page removed the funding-status notice about potential delays due to government funding, removing a site-wide operational alert. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-13T22:44:06.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    No additions or deletions of significant content were detected, and the page content remains unchanged.
    Difference
    0.3%
    Check dated 2025-10-30T13:16:48.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Major update to display a government-operation status notice and newer version tag (v3.2.0); removal of an old resource entry (Small cell lung carcinoma) and older version tag (v3.0.2).
    Difference
    2%
    Check dated 2025-10-02T01:24:03.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    - Added: Revision: v3.1.0. - Removed: Genetic and Rare Diseases Information Center resources: Small cell lung carcinoma and Revision: v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-30T13:43:47.000Z thumbnail image

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.